Epitope characterization and variable region sequence of F1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type A (Hall strain)

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Scotcher, Miles C ^a   McGarvey, Jeffery A ^a   Johnson, Eric A ^b   Stanker, Larry H ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BOTULINUM TOXIN A; EPITOPE; GLYCINE; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F1 40; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG; HYBRID PROTEIN; PRIMER DNA;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CLOSTRIDIUM BOTULINUM; COMPUTER MODEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; HEAVY CHAIN; IMMUNOASSAY; LIGHT CHAIN; MOLECULAR CLONING; NONHUMAN; PHAGE DISPLAY; PLASMID; PROTEIN EXPRESSION; WESTERN BLOTTING; ANTIBODY AFFINITY; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM BOTULINUM;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; BASE SEQUENCE; BLOTTING, WESTERN; BOTULINUM TOXIN TYPE A; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PLASMIDS; RECOMBINANT FUSION PROTEINS;

EID: 62849092267     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004924     Document Type: Article

References (42)

1. Lamanna C (1959) The most poisonous poison. Science 130: 763-772.
2. Hatheway CL (1990) Toxigenic clostridia. Clin Microbiol Rev 3(1): 66-98.
3. Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, et al. (2005) Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infection and immunity 73(9): 5450-5457.
4. Niwa K, Koyama K, Inoue S, Suzuki T, Hasegawa K, et al. (2007) Role of nontoxic components of serotype D botulinum toxin complex in permeation through a Caco-2 cell monolayer, a model for intestinal epithelium. FEMS Immunol Med Microbiol 49(3): 346-352.
5. Montecucco C, Schiavo G (1993) Tetanus and botulism neurotoxins: a new group of zinc proteases. Trends Biochem Sci 18(9): 324-327.
6. Montecucco C, Schiavo G (1994) Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 13(1): 1-8.
7. Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5(10): 898-902.
8. Wu HC, Yeh CT, Huang YL, Tarn LJ, Lung CC (2001) Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A. Appl Environ Microbiol 67(7): 3201-3207.
9. Gill DM (1982) Bacterial toxins: a table of lethal amounts. Microbiol Rev 46(1): 86-94.
10. Brin MF (1997) Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 6: S146-168.
11. Sobel J (2005) Botulism. Clin Infect Dis 41(8): 1167-1173.
12. CDC (2007) Botulism associated with commercially canned chili sauce-Texas and Indiana, July 2007. MMWR Morb Mortal Wkly Rep 56(30): 767-769.
13. Gibb G (2007) Castleberry's Foods: A Modern-Day Botulism Scare. Available: http://www.lawyersandsettlements.com/articles/01266/ castleberry-canned-meat-recall.html.
14. Reynolds G (2007) Castleberry's recall could cost $35m. Available: http://www.foodproductiondaily-usa.com/news/ ng.asp?id=79051-castleberry-s-contamination-recall.
15. Zilinskas RA (1997) Iraq's biological weapons. The past as future? Jama 278(5): 418-424.
16. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, et al. (2001) Botulinum toxin as a biological weapon: medical and public health management. JAMA 85(8): 1059-1070.
17. Wein LM, Liu Y (2005) Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk. Proceedings of the National Academy of Sciences of the United States of America 102(28): 9984-9989.
18. Sharma SK, Whiting RC (2005) Methods for detection of Clostridium botulinum toxin in foods. J Food Prot 68(6): 1256-1263.
19. Lindstrom M, Korkeala H (2006) Laboratory diagnostics of botulism. Clin Microbiol Rev 19(2): 298-314.
20. Stanker LH, Merrill P, Scotcher MC, Cheng LW (2008) Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA. Journal of immunological methods 336(1): 1-8.
21. Levy R, Forsyth CM, LaPorte SL, Geren IN, Smith LA, et al. (2007) Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. Journal of molecular biology 365(1): 196-210.
22. Adekar SP, Takahashi T, Jones RM, Al-Saleem FH, Ancharski DM, et al. (2008) Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain. PLoS ONE 3(8): e3023.
23. Cheng L, Stanker LH, Henderson TD, Scotcher MC (2008) Antibody protection of mice from botulinum intoxication; 45th Interagency Botulinum Research Coordinating Committee Meeting; Philadelphia, PA. pp VA-8.
24. Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press.
25. Hengen PN (1996) Methods and reagents. Purification of GST fusion proteins. Trends Biochem Sci 21(10): 400-401.
26. Morrison S (2002) Cloning, expression and modification of antibody V regions. Current Protocols in Immunology. pp 2.12.11 to 12.12.17.
27. Wood DL, Coleclough C (1984) Different joining region J elements of the murine kappa immunoglobulin light chain locus are used at markedly different frequencies. Proceedings of the National Academy of Sciences of the United States of America 81(15): 4756-4760.
28. Recinos A 3rd, Silvey KJ, Ow DJ, Jensen RH, Stanker LH (1994) Sequences of cDNAs encoding immunoglobulin heavy- and light-chain variable regions from two anti-dioxin monoclonal antibodies. Gene 149(2): 385-386.
29. Recinos A 3rd, Silvey KJ, Ow DJ, Jensen RH, Stanker LH (1995) Sequences of cDNAs encoding immunoglobulin heavy- and light-chain variable regions from two anti-dioxin monoclonal antibodies [Gene 149 (1994) 385-386]. Gene 158(2): 311-312.
30. Livesay DR, Subramaniam S (2004) Conserved sequence and structure association motifs in antibody-protein and antibody-hapten complexes. Protein Eng Des Sel 17(5): 463-472.
31. Swaminathan S, Eswaramoorthy S (2000) Structural analysis of the catyalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol 7(8): 693-699.
32. Agarwal R, Eswaramoorthy S, Kumaran D, Binz T, Swaminathan S (2004) Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212→Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway. Biochemistry 43(21): 6637-6644.
33. Agarwal R, Binz T, Swaminathan S (2005) Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design. Biochemistry 44(35): 11758-11765.
34. Arndt JW, Yu W, Bi F, Stevens RC (2005) Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition. Biochemistry 44(28): 9574-9580.
35. Arndt JW, Chai Q, Christian T, Stevens RC (2006) Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity. Biochemistry 45(10): 3255-3262.
36. Dolimbek BZ, Steward LE, Aoki KR, Atassi MZ (2008) Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin. Mol Immunol 45(4): 910-924.
37. Mullaney BP, Pallavicini MG, Marks JD (2001) Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display. Infection and immunity 69(10): 6511-6514.
38. Hill HR, Stockley PG (1996) Phage presentation. Mol Microbiol 20(4): 685-692.
39. Manoutcharian K, Gevorkian G, Cano A, Almagro JC (2001) Phage displayed biomolecules as preventive and therapeutic agents. Curr Pharm Biotechnol 2(3): 217-223.
40. Li Y, Ning YS, Wang YD, Hong YH, Luo J, et al. (2007) Production of mouse monoclonal antibodies against Helicobacter pylori Lpp20 and mapping the antigenic epitope by phage display library. Journal of immunological methods 325(1-2): 1-8.
41. Li Y, Ning YS, Wang YD, Luo J, Wang W, et al. (2008) Production of mouse monoclonal antibodies against Helicobacter pylori Catalase and mapping the antigenic epitope by phage display library. Vaccine 26(9): 1263-1269.
42. Kabat EA, Wu TT, Reid-Miller M, Perry H, Gottesman K (1987) Sequences of Proteins of Immunological Interest, Fourth Edition: US Department of Health and Human Services, Public Health Service, National Institute of Health, Bethesda, MD.